NOVEL CRYSTALLINE FORMS

The present invention is directed to novel crystalline forms of 5-(4-{[2-fluorophenyl)methyl]oxy}phenyl-prolinamide hydrochloride, to the use of said crystalline forms in treating diseases and conditions mediated by modulation of voltage-gated sodium channels, to compositions containing said crystal...

Full description

Saved in:
Bibliographic Details
Main Authors GOPINATHAN, Nishanth, VASUDEVAN, Kalyan, TRAN, Kenny, IRDAM, Erwin, KWOK, Daw-Long, Albert, LIN, Yiqing, KIESMAN, William, OSEI-YEBOAH, Frederick, PETERSON, Matthew
Format Patent
LanguageEnglish
French
German
Published 09.06.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to novel crystalline forms of 5-(4-{[2-fluorophenyl)methyl]oxy}phenyl-prolinamide hydrochloride, to the use of said crystalline forms in treating diseases and conditions mediated by modulation of voltage-gated sodium channels, to compositions containing said crystalline forms and processes for their preparation.
Bibliography:Application Number: EP20180802201